Annual EBIT
$122.01 M
+$172.85 M+340.01%
December 31, 2023
Summary
- As of February 7, 2025, VYGR annual earnings before interest & taxes is $122.01 million, with the most recent change of +$172.85 million (+340.01%) on December 31, 2023.
- During the last 3 years, VYGR annual EBIT has risen by +$94.63 million (+345.57%).
- VYGR annual EBIT is now at all-time high.
Performance
VYGR EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$13.78 M
+$1.25 M+8.29%
September 30, 2024
Summary
- As of February 7, 2025, VYGR quarterly earnings before interest & taxes is -$13.78 million, with the most recent change of +$1.25 million (+8.29%) on September 30, 2024.
- Over the past year, VYGR quarterly EBIT has dropped by -$67.84 million (-125.49%).
- VYGR quarterly EBIT is now -111.21% below its all-time high of $122.88 million, reached on March 31, 2023.
Performance
VYGR Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
$9.07 M
+$15.73 M+236.43%
September 30, 2024
Summary
- As of February 7, 2025, VYGR TTM earnings before interest & taxes is $9.07 million, with the most recent change of +$15.73 million (+236.43%) on September 30, 2024.
- Over the past year, VYGR TTM EBIT has dropped by -$112.94 million (-92.56%).
- VYGR TTM EBIT is now -92.56% below its all-time high of $122.01 million, reached on December 31, 2023.
Performance
VYGR TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
VYGR EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +340.0% | -125.5% | -92.6% |
| 3 y3 years | +345.6% | +43.9% | +117.8% |
| 5 y5 years | +233.9% | +43.9% | +117.8% |
VYGR EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +265.7% | -111.2% | +53.3% | -92.6% | +112.3% |
| 5 y | 5-year | at high | +265.7% | -111.2% | +53.3% | -92.6% | +108.8% |
| alltime | all time | at high | +233.9% | -111.2% | +53.3% | -92.6% | +108.8% |
Voyager Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$13.78 M(-8.3%) | $9.07 M(-236.4%) |
| Jun 2024 | - | -$15.03 M(-7.2%) | -$6.65 M(-61.0%) |
| Mar 2024 | - | -$16.18 M(-129.9%) | -$17.05 M(-114.0%) |
| Dec 2023 | $122.01 M(-340.0%) | $54.06 M(-283.2%) | $122.01 M(+181.2%) |
| Sep 2023 | - | -$29.51 M(+16.1%) | $43.39 M(-50.3%) |
| Jun 2023 | - | -$25.43 M(-120.7%) | $87.34 M(-6.5%) |
| Mar 2023 | - | $122.88 M(-600.3%) | $93.40 M(-283.7%) |
| Dec 2022 | -$50.84 M(-30.9%) | -$24.56 M(-270.1%) | -$50.84 M(+147.1%) |
| Sep 2022 | - | $14.44 M(-174.6%) | -$20.57 M(-65.8%) |
| Jun 2022 | - | -$19.37 M(-9.3%) | -$60.16 M(-13.3%) |
| Mar 2022 | - | -$21.35 M(-474.4%) | -$69.38 M(-5.8%) |
| Dec 2021 | -$73.62 M(-368.8%) | $5.70 M(-122.7%) | -$73.62 M(-28.6%) |
| Sep 2021 | - | -$25.15 M(-12.0%) | -$103.05 M(-1655.7%) |
| Jun 2021 | - | -$28.59 M(+11.7%) | $6.62 M(-74.7%) |
| Mar 2021 | - | -$25.59 M(+7.8%) | $26.23 M(-4.2%) |
| Dec 2020 | $27.38 M(-153.0%) | -$23.73 M(-128.1%) | $27.38 M(-26.7%) |
| Sep 2020 | - | $84.53 M(-1041.2%) | $37.34 M(-157.5%) |
| Jun 2020 | - | -$8.98 M(-63.2%) | -$64.99 M(+38.8%) |
| Mar 2020 | - | -$24.43 M(+77.5%) | -$46.82 M(-9.4%) |
| Dec 2019 | -$51.68 M | -$13.77 M(-22.7%) | -$51.68 M(-15.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2019 | - | -$17.81 M(-293.8%) | -$61.07 M(-5.2%) |
| Jun 2019 | - | $9.19 M(-131.4%) | -$64.41 M(-35.1%) |
| Mar 2019 | - | -$29.29 M(+26.5%) | -$99.30 M(+9.0%) |
| Dec 2018 | -$91.09 M(+26.8%) | -$23.16 M(+9.5%) | -$91.09 M(+13.5%) |
| Sep 2018 | - | -$21.15 M(-17.7%) | -$80.28 M(-2.7%) |
| Jun 2018 | - | -$25.69 M(+21.8%) | -$82.49 M(+9.4%) |
| Mar 2018 | - | -$21.09 M(+70.8%) | -$75.44 M(+5.0%) |
| Dec 2017 | -$71.86 M(+74.0%) | -$12.35 M(-47.1%) | -$71.86 M(-2.0%) |
| Sep 2017 | - | -$23.36 M(+25.3%) | -$73.36 M(+21.5%) |
| Jun 2017 | - | -$18.64 M(+6.4%) | -$60.37 M(+17.6%) |
| Mar 2017 | - | -$17.52 M(+26.6%) | -$51.35 M(+24.3%) |
| Dec 2016 | -$41.30 M(+103.9%) | -$13.84 M(+33.5%) | -$41.30 M(+18.3%) |
| Sep 2016 | - | -$10.37 M(+7.8%) | -$34.90 M(+22.3%) |
| Jun 2016 | - | -$9.62 M(+28.8%) | -$28.54 M(+24.7%) |
| Mar 2016 | - | -$7.47 M(+0.4%) | -$22.89 M(+13.0%) |
| Dec 2015 | -$20.25 M(+41.0%) | -$7.44 M(+85.1%) | -$20.25 M(+17.0%) |
| Sep 2015 | - | -$4.02 M(+1.3%) | -$17.31 M(+2.1%) |
| Jun 2015 | - | -$3.97 M(-17.8%) | -$16.95 M(+30.6%) |
| Mar 2015 | - | -$4.83 M(+7.4%) | -$12.98 M(+59.2%) |
| Dec 2014 | -$14.37 M | -$4.50 M(+23.0%) | -$8.15 M(+123.0%) |
| Sep 2014 | - | -$3.66 M | -$3.66 M |
FAQ
- What is Voyager Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Voyager Therapeutics?
- What is Voyager Therapeutics annual EBIT year-on-year change?
- What is Voyager Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Voyager Therapeutics?
- What is Voyager Therapeutics quarterly EBIT year-on-year change?
- What is Voyager Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Voyager Therapeutics?
- What is Voyager Therapeutics TTM EBIT year-on-year change?
What is Voyager Therapeutics annual earnings before interest & taxes?
The current annual EBIT of VYGR is $122.01 M
What is the all time high annual EBIT for Voyager Therapeutics?
Voyager Therapeutics all-time high annual earnings before interest & taxes is $122.01 M
What is Voyager Therapeutics annual EBIT year-on-year change?
Over the past year, VYGR annual earnings before interest & taxes has changed by +$172.85 M (+340.01%)
What is Voyager Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of VYGR is -$13.78 M
What is the all time high quarterly EBIT for Voyager Therapeutics?
Voyager Therapeutics all-time high quarterly earnings before interest & taxes is $122.88 M
What is Voyager Therapeutics quarterly EBIT year-on-year change?
Over the past year, VYGR quarterly earnings before interest & taxes has changed by -$67.84 M (-125.49%)
What is Voyager Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of VYGR is $9.07 M
What is the all time high TTM EBIT for Voyager Therapeutics?
Voyager Therapeutics all-time high TTM earnings before interest & taxes is $122.01 M
What is Voyager Therapeutics TTM EBIT year-on-year change?
Over the past year, VYGR TTM earnings before interest & taxes has changed by -$112.94 M (-92.56%)